Weill Cornell College of Medicine, New York, USA.
Organogenesis. 2011 Apr-Jun;7(2):96-100. doi: 10.4161/org.7.2.15781. Epub 2011 Apr 1.
An extensive body of preclinical and clinical data has shown that administration of adult multipotent marrow stromal cells (MSCs) effectively ameliorates experimental and clinical conditions of many different organ systems. Differentiation into organ parenchymal cells, however, is very rare, and the main mechanism for organ protection and regeneration from different types of injury is the exertion of paracrine effects and stimulation of tissue repair. A large number of clinical trials have been conducted and are ongoing to investigate the safety and efficacy of MSCs in different organs after various types of organ injury. This article intends to give a brief overview about current applications of MSCs and mechanisms involved in organ protection and regeneration.
大量的临床前和临床数据表明,成年多能骨髓基质细胞(MSCs)的给药可有效改善许多不同器官系统的实验和临床状况。然而,向器官实质细胞分化非常罕见,不同类型损伤的器官保护和再生的主要机制是发挥旁分泌作用和刺激组织修复。已经进行了大量的临床试验,并正在进行中,以研究不同类型器官损伤后 MSCs 在不同器官中的安全性和有效性。本文旨在简要概述 MSCs 的当前应用及其在器官保护和再生中涉及的机制。